Evidence map›Paper›PMID 28122883›Full record

ArticleCirculation2017

Retinol-Binding Protein-Dependent Cholesterol Uptake Regulates Macrophage Foam Cell Formation and Promotes Atherosclerosis.

Yan Liu, Yuan Zhong, Hongen Chen, Duan Wang, Min Wang, Jing-Song Ou, Min Xia

Erratum issuedOpen access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Circulation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 55 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 2 pooled it
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 2 syntheses or guidelines pooled it, 92 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. RBP4 in Ageing.Biomedicines · 2026
    Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Biochemical Markers of Bone Fragility in Patients with DiabetesThe Journal of clinical endocrinology and metabolism · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Yan LiuFrom Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Guangzhou, People's Republic of China (Y.L., Y.Z., H.C., D.W., M.W., M.X.); Department of Nutrition, School of Public Health, Sun Yat-sen University (Northern Campus), Guangzhou, Guangdong Province, People's Republic of China (Y.L., Y.Z., H.C., D.W., M.W., M.X.); State Key Laboratory of Pharmaceutical Biotechnology, Department of Medicine, University of Hong Kong, People's Republic of China (Y.L.); and Division of Cardiac Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China (J.-S.O.).
Yuan ZhongFrom Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Guangzhou, People's Republic of China (Y.L., Y.Z., H.C., D.W., M.W., M.X.); Department of Nutrition, School of Public Health, Sun Yat-sen University (Northern Campus), Guangzhou, Guangdong Province, People's Republic of China (Y.L., Y.Z., H.C., D.W., M.W., M.X.); State Key Laboratory of Pharmaceutical Biotechnology, Department of Medicine, University of Hong Kong, People's Republic of China (Y.L.); and Division of Cardiac Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China (J.-S.O.).
Hongen ChenFrom Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Guangzhou, People's Republic of China (Y.L., Y.Z., H.C., D.W., M.W., M.X.); Department of Nutrition, School of Public Health, Sun Yat-sen University (Northern Campus), Guangzhou, Guangdong Province, People's Republic of China (Y.L., Y.Z., H.C., D.W., M.W., M.X.); State Key Laboratory of Pharmaceutical Biotechnology, Department of Medicine, University of Hong Kong, People's Republic of China (Y.L.); and Division of Cardiac Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China (J.-S.O.).
Duan WangFrom Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Guangzhou, People's Republic of China (Y.L., Y.Z., H.C., D.W., M.W., M.X.); Department of Nutrition, School of Public Health, Sun Yat-sen University (Northern Campus), Guangzhou, Guangdong Province, People's Republic of China (Y.L., Y.Z., H.C., D.W., M.W., M.X.); State Key Laboratory of Pharmaceutical Biotechnology, Department of Medicine, University of Hong Kong, People's Republic of China (Y.L.); and Division of Cardiac Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China (J.-S.O.).
Min WangFrom Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Guangzhou, People's Republic of China (Y.L., Y.Z., H.C., D.W., M.W., M.X.); Department of Nutrition, School of Public Health, Sun Yat-sen University (Northern Campus), Guangzhou, Guangdong Province, People's Republic of China (Y.L., Y.Z., H.C., D.W., M.W., M.X.); State Key Laboratory of Pharmaceutical Biotechnology, Department of Medicine, University of Hong Kong, People's Republic of China (Y.L.); and Division of Cardiac Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China (J.-S.O.).
Jing-Song OuFrom Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Guangzhou, People's Republic of China (Y.L., Y.Z., H.C., D.W., M.W., M.X.); Department of Nutrition, School of Public Health, Sun Yat-sen University (Northern Campus), Guangzhou, Guangdong Province, People's Republic of China (Y.L., Y.Z., H.C., D.W., M.W., M.X.); State Key Laboratory of Pharmaceutical Biotechnology, Department of Medicine, University of Hong Kong, People's Republic of China (Y.L.); and Division of Cardiac Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China (J.-S.O.).
Min XiaFrom Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Guangzhou, People's Republic of China (Y.L., Y.Z., H.C., D.W., M.W., M.X.); Department of Nutrition, School of Public Health, Sun Yat-sen University (Northern Campus), Guangzhou, Guangdong Province, People's Republic of China (Y.L., Y.Z., H.C., D.W., M.W., M.X.); State Key Laboratory of Pharmaceutical Biotechnology, Department of Medicine, University of Hong Kong, People's Republic of China (Y.L.); and Division of Cardiac Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China (J.-S.O.). xiamin@mail.sysu.edu.cn.
University of Hong Kong · HKKey Laboratory of Guangdong Province · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRetinol-binding protein 4 (RBP4) is an adipokine that plays decisive roles in glucose metabolism and insulin sensitivity. Elevated circulating RBP4 levels were reported to be associated with increased risk for cardiovascular disease, but the precise role of RBP4 in atherosclerotic diseases and its mechanisms of action remain elusive.

methodsSerum RBP4 levels of 1683 participants from South China were evaluated and the occurrence of major adverse cardiovascular events was followed up for 5 years. Apolipoprotein E-deficient mice infected with RBP4-overexpressing/silencing adenovirus, J774A.1 macrophages, and primary peritoneal macrophages from RBP4 transgenic mice were used for investigating the function of RBP4 in foam cell formation.

resultsProspective cohort studies revealed that baseline serum RBP4 level was an independent predictor for incidence of adverse cardiovascular events after adjustment for traditional risk factors. Increased RBP4 expression was observed in atherosclerotic lesions of aortic specimens from both humans and apolipoprotein E-deficient mice, and RBP4 was localized to areas rich in macrophage foam cells. RBP4 inhibition attenuated whereas overexpression accelerated atherosclerosis progression in apolipoprotein E-deficient mice. Both treatment with exogenous recombinant RBP4 and overexpression of RBP4 gene promoted macrophage-derived foam cell formation through the activation of scavenger-receptor CD36-mediated cholesterol uptake, and RBP4 transcriptionally upregulated CD36 expression in a manner dependent on jun N-terminal kinase and signal transducer and activator of transcription 1. The tyrosine kinase c-Src was identified as the upstream regulator of jun N-terminal kinase-signal transducer and activator of transcription 1-mediated CD36-dependent cholesterol uptake, and RBP4 challenge was found to alter the membrane distribution of c-Src and cause c-Src to partition into lipid-raft membrane subdomains, where the kinase was activated. Lastly, Toll-like receptor 4, but not retinol or stimulated by retinoic acid 6, mediated the inductive effects of RBP4 in macrophages.

conclusionsInclusion of RBP4 levels in traditional models enhances the predictive ability for the incidence of atherosclerotic events. RBP4 promotes atherogenesis by inducing macrophage-derived foam cell formation.

Indexed as

AnimalsApolipoproteins EAtherosclerosisCarrier ProteinsCohort StudiesFoam CellsHumansMacrophagesMaleMiceMice, Inbred C57BLPancreatic ElastaseProspective StudiesRetinol-Binding Proteins, PlasmaApolipoproteins ECarrier Proteinscholesterol-binding proteinPancreatic ElastaseRbp4 protein, mouseRetinol-Binding Proteins, PlasmaatherosclerosisCD36cholesterol uptakeRBP4

Identifiers

PMID28122883
OpenAlexW2580064798

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.